Compare LEN & IFF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEN | IFF |
|---|---|---|
| Founded | 1954 | 1833 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Major Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.4B | 20.0B |
| IPO Year | 1996 | 2010 |
| Metric | LEN | IFF |
|---|---|---|
| Price | $85.48 | $81.10 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 15 | 12 |
| Target Price | ★ $97.23 | $89.09 |
| AVG Volume (30 Days) | ★ 2.3M | 1.7M |
| Earning Date | 06-15-2026 | 05-05-2026 |
| Dividend Yield | 2.25% | ★ 2.32% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.17 | 0.85 |
| Revenue | ★ $34,186,934,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.41 | $3.11 |
| P/E Ratio | ★ $39.88 | $96.27 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $79.83 | $59.14 |
| 52 Week High | $144.24 | $89.32 |
| Indicator | LEN | IFF |
|---|---|---|
| Relative Strength Index (RSI) | 49.11 | 51.17 |
| Support Level | $85.07 | $72.84 |
| Resistance Level | $88.27 | $84.06 |
| Average True Range (ATR) | 2.41 | 2.05 |
| MACD | 0.20 | -0.19 |
| Stochastic Oscillator | 57.04 | 30.60 |
Lennar is the second-largest public homebuilder in the United States, behind D.R. Horton, operating in 26 states. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily construction and has invested in numerous housing-related technology startups.
International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations and partners with customers to deliver custom solutions. Through its taste and scent segments, which each generate around 25% of profits, IFF is a leading flavor and fragrance producer. The health and biosciences business, which generates 30% of profits, is a global leader in probiotics and enzymes. The remaining profits come from the food ingredients business, which sells texturants, plant-based proteins, and other ingredients, though IFF plans to divest it in a deal expected to close in 2027.